​​​​​Michael J. A. Walker, PhD


Dr. Walker received his pharmacology training at the University of London which, included a period of drug discovery training at Pfizer Ltd., (UK). His main focus has been in the discovery of drugs, whether naturally occurring or not, and in the process of drug discovery itself.  His commitment to his industry includes 43 years at UBC and numerous contributions to universities around the world.  Over the past 25 years, Dr. Walker was the founder or co-founder of eight different drug discovery companies, both public and private, including Cardiome Pharma (TSX:COM) in Canada and Verona Pharma Ltd. in London. Additionally, Dr. Walker has researched and published numerous, journals, periodicals, conference presentations, and other related publications.